Gupta, 65, reported to the minimum security satellite camp at FMC Devens in Ayer, Massachusetts on June 17.
Interception of electronic communication should also be covered in the powers being sought, the report said.
'The markets haven't corrected, that doesn't mean that they will only go up and up.'
Securities and Exchange Board of India (Sebi) chairman Ajay Tyagi on Thursday defended the recent reforms announced by the regulator, such as peak margin norms and shortening of the trade settlement cycle, saying they were in the interest of investors. The moves were criticised by the broking community and the foreign portfolio investors (FPIs). Speaking to the media after his inaugural address at the CII Financial Markets Summit, Tyagi said: "The new peak margin norms are in everyone's interest.
Promoters and top executives intending to buy or sell shares of their companies might soon have to inform the market well in advance for such transactions.
As the industrial era wanes, the network era looms, notes Ajit Balakrishnan.
.jpg)
The ruling by the Supreme Court was made in a parallel civil insider trading case brought against Gupta by federal regulator Securities and Exchange Commission.
Reema Shah pleaded guilty to insider trading and cooperated with the US government for accepting insider info from a Yahoo! executive
CID investigating officer Lakshmi Narayana Rao asked Chandrababu to appear in person at the CID regional office in Vijayawada on March 23 "to examine you (A-1) in the above crime, to ascertain facts which are within your exclusive knowledge."
In an open letter to Zee's shareholders, Invesco, which holds a 7.74 per cent stake in the firm, reiterated its demand for an overhaul of the media group's board and that it would pursue extraordinary general meeting (EGM) to oust chief executive Punit Goenka and two other directors. Last month, Sony Group Corp's India unit signed a non-binding offer to buy Zee.
Gupta's lawyers said he did not accrue any 'direct financial benefit' from the insider trading offences and yet he has been ordered to pay a 'heavy price' of two years in prison, a $5 million fine and a separate $6 million in restitution to Goldman Sachs.
A US court has denied a bid by billionaire hedge fund founder Raj Rajaratnam, convicted in May this year on insider trading charges, to reverse the verdict handed by the jury in his case.
Rajat Gupta was convicted in 2012 of passing confidential boardroom information to now jailed hedge fund founder Raj Rajaratnam.
Future Retail Ltd (FRL) on Monday said the Delhi high court has ruled that statutory authorities cannot be restrained from acting in accordance with law and stayed a previous order on status quo of its Rs 24,713 crore deal with Reliance. Updating stock exchanges about the court ruling, FRL said a Division Bench comprising Chief Justice D N Patel and Justice Jyoti Singh has stayed the operation and effect of order passed by single Judge J R Midha on February 2. "...inter alia, for the prima facie reason that the company is not a party to the Shareholders Agreement dated August 22, 2019 executed between Amazon, Future Coupons Private Limited and the Promoters of FRL, under which arbitration was initiated by Amazon in Singapore," FRL said.
Martoma, 40, was ordered by US District Judge Paul Gardephe to surrender by Thursday afternoon, after he lost his bid last week to remain free on bail pending appeal of his conviction.
He was convicted in his 2012 trial of passing confidential boardroom information to his one-time friend and business associate Raj Rajaratnam
Since Reliance senior counsel Janak Dwarkadas could not be present in the courtroom due to a medical emergency, the company sought adjournment, following which the tribunal agreed to hear the matter on April 16.
Future Retail Ltd has said that SEBI's one-year ban on its chairman Kishore Biyani and some other promoters from the securities market will have "no impact" on the Rs 24,713 crore-deal with Reliance. Further, Kishore Biyani, some other promoters and Future Corporate Resources Pvt Ltd (FCRPL) plan to appeal against the order passed by Securities and Exchange Board of India (SEBI) on Wednesday. "The order will have no impact on the ongoing Scheme of Arrangement of the company. We understand that the relevant parties propose to challenge this order in exercise of their statutory right to appeal," Future Retail Ltd (FRL) said in a late-night regulatory filing on Wednesday.
The former employer incurred the amount as legal expenses during the trial.
When important people are involved in insider trading, only quick and firm action against them sends a powerful message.
Based on a writ petition filed by some individual investors, the High Court while ordering the status quo on Friday, issued notices to SEBI, BSE, NSE, Sun Pharma, Ranbaxy, Daichii Sankyo and Silver Street Developers.
Head of investor relations T A N Murti allegedly indulged in insider trading during the sacm.
The political economy of the IPO market involves regulators empathising with intermediaries, and designing a bridge that systematically takes wealth away from founders, VC and PE funds, and business houses, explains Ajay Shah.
Gupta, 63, read from a prepared statement for six minutes before being sentenced.
The Diwali of 2011 saw Gupta surrender himself before the FBI after charges of insider trading were filed against him by Manhataan's top federal prosecutor India-born Preet Bharara.
The Diwali of 2011 saw Gupta surrender himself before the FBI after charges of insider trading were filed against him by Manhataan's top federal prosecutor India-born Preet Bharara.
Pharma major Sun Pharma remained the worst loser in the Sensex pack for the second day in a row after reports that regulator Sebi may reopen the insider trading case against the company.
Executive is facing probe for allegedly leaking confidential information to former Galleon Group co-founder Raj Rajaratnam.
The prosecution and defense presented their closing arguments in the high-profile insider trading trial of Gupta in Manhattan federal court on Wednesday.
FPIs would be classified into two categories instead of three, while the requirements for issuance and subscription of offshore derivative instruments would be rationalised.
Based on a petition filed by two individual investors, the court on April 25, issued interim 'status quo' orders on the merger process.
Shah had pleaded guilty in 2012 to securities fraud in a parallel civil insider trading case case.
The sentence -- which some legal considered light -- seemed to be the result of the consideration by the court that Rajaratnam, 54, was apparently in poor health and despite being on the wrong side of the law, had contributed over the years to charities and for benevolent activities.
His conviction on insider trading charges exposed a "web of fraud and corruption that entangled many."
The appeals court granted Martoma's request to extend his November 10 surrender date until an appellate panel hears and decides on his motion for bail pending appeal.
Gambling debt, stock tip lead to $1 million settlement but no charges for golfer Phil Mickelson.
Rajat Gupta, 70, the first Indian managing director of McKinsey and who of 17 months in US prison for insider trading, gets ready to tell his side of the story. And he is less than complimentary about Preet Bharara, then the famous crusading US attorney for the Southern District of New York. "The jury, the press and the public saw only... a 'cropped picture', he says. For someone whose life story was a model of the Great American Dream - an Indian of modest means who rose to the highest circles of politics and business, mingling with the White House and Davos crowd - his indictment in 2012 marked a stunning fall from grace. Many ascribed it to the hubris of the rich and powerful, says Kanika Datta.
Galleon Group founder Raj Rajaratnam's defence team have rested their case in the biggest hedge fund insider trading trial in the US history. Rajaratnam's defence rested their case on Monday.
The tribunal, which had concluded its hearings on two petitions from RIL on January 6 and reserved its order for an unspecified date, set February 24 for the next hearing.
Prosecutors unveiled charges against Valvani alleging he fraudulently made $25 million by getting advance information about US Food and Drug Administration approvals of generic drug applications
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances